Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure

被引：0
|
作者：
Wei-Lin Liang
Bo Liang
机构：
[1] Guangyuan Hospital of Chinese Medicine,Department of Cardiology
[2] Xinqiao Hospital,Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases
[3] Army Medical University (Third Military Medical University),undefined
来源：
Current Cardiology Reports | 2023年 / 25卷
关键词：
Heart failure; Cardiac pharmacology; Soluble guanylate cyclase activators and stimulators; Cinaciguat; Riociguat; Vericiguat; Praliciguat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：607 / 613
页数：6
相关论文
共 50 条
  • [31] Comparison of soluble guanylate cyclase stimulators and activators in models of cardiovascular disease associated with oxidative stress
    Costell, Melissa H.
    Ancellin, Nicolas
    Bernard, Roberta E.
    Zhao, Shufang
    Upson, John J.
    Morgan, Lisa A.
    Maniscalco, Kristeen
    Olzinski, Alan R.
    Ballard, Victoria L. T.
    Herry, Kenny
    Grondin, Pascal
    Dodic, Nerina
    Mirguet, Olivier
    Bouillot, Anne
    Gellibert, Francoise
    Coatney, Robert W.
    Lepore, John J.
    Jucker, Beat M.
    Jolivette, Larry J.
    Willette, Robert N.
    Schnackenberg, Christine G.
    Behm, David J.
    FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [32] Safety And Effect on Mortality of Soluble Guanylate Cyclase Stimulators In Heart Failure Patients- A Systemic Review And Meta-analysis
    Asif, Anum
    Rawala, Muhammad Shabbir
    Ahmed, Faiza
    Shahatit, Rawan
    Aggarwal, Sandeep
    Siddiqui, Waqas Javed
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S39 - S39
  • [33] SOLUBLE GUANYLATE CYCLASE STIMULATORS: AN EMERGING OPTION IN THE TREATMENT OF PRESSURE AND VOLUME OVERLOAD INDUCED CHRONIC HEART FAILURE
    Bacova, Barbara Szeiffova
    Sykora, Matus
    Martiskova, Adriana
    Gawrys, Olga
    Tribulova, Narcisa
    Cervenka, Ludek
    JOURNAL OF HYPERTENSION, 2024, 42 (SUPPL 3)
  • [34] SOLUBLE GUANYLATE CYCLASE STIMULATORS IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Zhao, Yang
    Zang, Bin
    Wang, Qian
    SHOCK, 2024, 61 (03): : 333 - 339
  • [35] The discovery and characterization of novel soluble guanylate cyclase stimulators
    Jaime L Masferrer
    BMC Pharmacology and Toxicology, 16 (Suppl 1)
  • [36] Exploring the Potential of NO-Independent Stimulators and Activators of Soluble Guanylate Cyclase for the Medical Treatment of Erectile Dysfunction
    Gur, Serap
    Kadowitz, Philip J.
    Hellstrom, Wayne J. G.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (14) : 1619 - 1633
  • [37] Soluble guanylate cyclase stimulators and activators: new horizons in the treatment of priapism associated with sickle cell disease
    Pereira, Dalila Andrade
    Silveira, Tammyris Helena Rebecchi
    Calmasini, Fabiano Beraldi
    Silva, Fabio Henrique
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [38] IMPACT OF ORAL SOLUBLE GUANYLATE CYCLASE STIMULATORS IN PATIENTS WITH HEART FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Moghaddam, Nima
    Malhi, Navraj
    Toma, Mustafa
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 665 - 665
  • [39] Vericiguat: A Novel Soluble Guanylate Cyclase Stimulator for Use in Patients With Heart Failure
    Gupta, Rahul
    Lin, Muling
    Maitz, Theresa
    Egeler, David J. J.
    Sood, Aayaan
    Aronow, Wilbert S. S.
    Rajeswaran, Yasotha
    Ahnert, Amy M. M.
    Vyas, Apurva V. V.
    Frishman, William H. H.
    Lanier, Gregg M. M.
    CARDIOLOGY IN REVIEW, 2023, 31 (02) : 87 - 92
  • [40] From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators
    Sandner, Peter
    BIOLOGICAL CHEMISTRY, 2018, 399 (07) : 679 - 690
12345